Mean, Median & Mode — Compute and interpret mean, median, mode

Long before modern biostatistics emerged as a formal discipline, scientists and administrators grappled with the challenge of summarizing large collections of numerical observations into single representative values. The need was intensely practical: governments required efficient ways to report population data, astronomers needed to reconcile discrepant measurements of celestial positions, and physicians sought to characterize 'normal' vital signs. The intellectual journey toward the mean, median, and mode spans several centuries and reflects evolving perspectives on what it means to capture the 'center' of a data distribution.

This history underscores a fundamental question that persists in modern biostatistical practice: which single number best represents the center of a dataset, and under what conditions does each measure yield the most faithful summary? The answer depends on the shape of the distribution, the type of variable, and the inferential goals of the analysis — all considerations we explore in the sections that follow.

Measures of central tendency serve a singular purpose: to distill a collection of observations into one value that captures where data points congregate. In biostatistics, where datasets may range from a handful of patient lab values to genome-wide expression arrays containing millions of entries, choosing the appropriate measure is not merely a computational decision — it is an inferential one. Each of the three classical measures — mean, median, and mode — encodes different assumptions about the data-generating process and responds differently to distributional features such as skewness, outliers, and multimodality.

The diagram above illustrates the fundamental geometric relationship among the three measures. Biostatistical datasets are frequently right-skewed — consider hospital costs, viral load counts, or time to disease recurrence — meaning that the mean will systematically overstate the 'typical' patient experience relative to the median. In clinical reporting, regulatory agencies such as the FDA therefore often request both the mean and median to ensure transparency, particularly when evaluating endpoints like overall survival or healthcare utilization. Recognizing the skewness signature at a glance, simply by noting how far the mean sits from the median, is one of the most useful quick-check skills in applied biostatistics.

Each measure of central tendency can be defined formally, enabling rigorous derivation of its statistical properties. Below we present the formulas for sample computations — the versions most commonly applied in biostatistical practice — alongside key mathematical properties that motivate their use.

From an estimation-theoretic perspective, the mean is the maximum likelihood estimator (MLE) of the population center when the underlying distribution is normal. Its variance equals σ²/n, meaning it becomes more precise as the sample size grows — a property formalized by the law of large numbers and the central limit theorem. The median, by contrast, has an asymptotic variance of π/(2n) × σ² ≈ 1.57σ²/n under normality, making it roughly 57% less efficient than the mean for Gaussian data. However, for heavy-tailed distributions common in biological data (e.g., lognormal drug concentrations), the median can actually be more efficient than the mean — a fact that underscores why the choice between these measures is fundamentally distribution-dependent.

Selecting the appropriate measure of central tendency is one of the first decisions in any biostatistical analysis, and the choice is governed by three interrelated factors: the measurement scale (nominal, ordinal, interval, ratio), the distributional shape (symmetric versus skewed), and the presence of outliers or censored observations. The flowchart below codifies these decision rules into a practical algorithm.

A nephrology research team measured serum creatinine (mg/dL) in 11 patients presenting with early-stage chronic kidney disease. The observed values were: 0.9, 1.1, 1.0, 1.3, 1.2, 1.1, 4.8, 1.0, 1.2, 1.1, 1.3. Note that one patient (4.8 mg/dL) has a markedly elevated value, suggesting advanced renal impairment — an outlier that will differentially affect the three measures.

No single measure of central tendency is universally superior; each carries a distinct set of strengths and weaknesses. The table below provides a systematic comparison along dimensions that matter most in biostatistical practice: sensitivity to outliers, algebraic tractability, applicability across measurement scales, and behavior under different distributional assumptions.

The mean, median, and mode are not isolated descriptive tools; they serve as conceptual and mathematical foundations for much of inferential biostatistics. Understanding how each measure connects to more advanced methods prepares you for the deeper analytical work encountered in clinical trial design, survival analysis, and machine learning for health data.

One especially important bridge concept is the Central Limit Theorem (CLT), which states that the sampling distribution of the mean approaches normality as sample size increases, regardless of the underlying population distribution (provided finite variance). This theorem justifies the widespread use of the mean in parametric inference. For the median, an analogous result holds: its sampling distribution is asymptotically normal with variance 1/(4nf(x̃)²), where f(x̃) is the population density evaluated at the true median. The practical implication is that both confidence intervals and hypothesis tests can be constructed around either measure for sufficiently large samples — though the choice of measure still affects interpretive meaning and statistical power.